Substrate
Topic

drug-shortages

2 stories related to this topic, newest first.

Medicare Spending on Newly Approved Alzheimer’s Drugs Leqembi and Kisunla Far Below Initial Projectionsfoxnews.com
health18 days agoDeveloping

Medicare Spending on Newly Approved Alzheimer’s Drugs Leqembi and Kisunla Far Below Initial Projections

Uptake of the recently approved intravenous Alzheimer’s medications has been far lower than anticipated, prompting Medicare to forecast no significant spending on Leqembi and Kisunla in 2026 or 2027. Two years ago the program projected billions of dollars annually on Leqembi alon…

Stat
1 source
FDA Withdraws Approval of GSK Drug; GLP-1 Generics Enter India Market; Estrogen Patches Face ShortageSubstrate placeholder — needs review
science49 days ago

FDA Withdraws Approval of GSK Drug; GLP-1 Generics Enter India Market; Estrogen Patches Face Shortage

The U.S. Food and Drug Administration withdrew approval for a GlaxoSmithKline drug previously promoted by the Trump administration for autism treatment. In India, generic versions of GLP-1 drugs are entering the obesity treatment market. A shortage of estrogen patches used for me…

ST
1 source